It mimics the bodys natural hormones to slow gastric emptying and suppress appetite
Meals built around lean proteins, cooked vegetables, whole foods, and healthy fats tend to be best tolerated
It stimulates both the GLP-1 and GIP receptors: it mimics the naturally present hormone and reduces gastric emptying while inducing more insulin secretion
It has not been approved by the FDA to treat any condition, and bodily introduction is not permitted
Understanding Weight Loss Rebound After Stopping Tirzepatide Clinical evidence shows that many patients regain 5075% of lost weight within 12 years after discontinuing GLP-1 or dual GIP/GLP-1 receptor agonists like tirzepatide
When multiple species of pregnant animals received topiramate at clinically relevant doses, structural malformations, including craniofacial defects, and reduced fetal weights occurred in offspring